MK-0653 ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
260	Sitosterolemia	2

260. Sitosterolemia

---

Clinical trials : 13 /  Drugs : 13 - (DrugBank : 4) / Drug target gene : 1 - Drug target pathway : 1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-001580-22-DE (EUCTR)	21/12/2004	20/10/2004	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to an Ongoing Regimen of Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia - Sitosterolemia High Dose Study	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to an Ongoing Regimen of Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia - Sitosterolemia High Dose Study	Homozygous Sitosterolemia	Trade Name: Ezetrol Product Name: Ezetrol Product Code: MK-0653	MSD SHARP & DOHME GMBH	NULL	Not Recruiting			Female: yes Male: yes	30		Germany;United Kingdom
2	EUCTR2004-001580-22-GB (EUCTR)	16/12/2004	24/02/2005	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to an Ongoing Regimen of Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia - Sitosterolemia High Dose Study	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to an Ongoing Regimen of Ezetimibe 10 mg in Patients With Homozygous Sitosterolemia - Sitosterolemia High Dose Study	Homozygous Sitosterolemia	Trade Name: Ezetrol Product Name: Ezetrol Product Code: MK-0653	Merck Sharp & Dohme Ltd	NULL	Not Recruiting			Female: yes Male: yes	30		Germany;United Kingdom